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Aluminium, the most abundant metal in the Earth\'s crust, has no recognized role in biological systems. Due to its versatile chemistry, aluminium is included in a variety of industrial products of daily use including food additives, anti‐acid drugs, household products, vaccines and cosmetics.[1](#ijc30393-bib-0001){ref-type="ref"}

Aluminium is generally assumed to be safe, but the biological consequences of its interaction with biological systems are largely unknown. Whereas its neurotoxic potential is generally acknowledged, little data exist on the effects of aluminium on the biology of mammalian cells. Aluminium has been reported to interfere with the binding of estradiol to estrogen receptor and to enhance transcription from an estrogen‐responsive element in a reporter system.[2](#ijc30393-bib-0002){ref-type="ref"}, [3](#ijc30393-bib-0003){ref-type="ref"} A genotoxic effect of aluminium has been reported in several systems, including human peripheral blood lymphocytes[4](#ijc30393-bib-0004){ref-type="ref"}, [5](#ijc30393-bib-0005){ref-type="ref"} (references therein).

Aluminium salts, contained in antiperspirants at concentrations up to several molar units (<http://www.fda.gov/RegulatoryInformation/Dockets/>ucm1303[50.htm](http://50.htm)), have been hypothesized to reach the mammary epithelium at significant doses as a consequence of daily application to the skin of the underarm, thus resulting in a continuous exposure. Consistent with this view, aluminium is adsorbed through the human and mouse skin,[6](#ijc30393-bib-0006){ref-type="ref"}, [7](#ijc30393-bib-0007){ref-type="ref"}, [8](#ijc30393-bib-0008){ref-type="ref"}, [9](#ijc30393-bib-0009){ref-type="ref"} and significant amounts of this metal have been measured in several compartments of the human breast including breast tissue, nipple aspirate fluid, breast cysts fluids and milk.^10--12^

In these studies, aluminium concentrations were higher in the external part of the mammary gland in the normal breast. Also, they were higher in breast cancer cases than in controls. These observations have led to the hypothesis that aluminium from antiperspirant use might contribute to the increased incidence of breast cancer observed in the western societies in the last few decades. In addition to increased incidence, a change in the topological distribution of breast cancers has also been reported, the majority of tumours arising nowadays in the external part of the mammary gland. It has been proposed that the latter change might be due to the application of an unidentified environmental carcinogen to the underarm area, with aluminium being a potential candidate.[2](#ijc30393-bib-0002){ref-type="ref"}, [13](#ijc30393-bib-0013){ref-type="ref"}

Due to widespread use of aluminium in antiperspirants, performing retrospective epidemiological studies on patients using *versus* patients non‐using aluminium salts as an antiperspirant is difficult. Therefore, the considerations on the carcinogenic potential of aluminium on the human breast have remained largely speculative in the clinics to date.

On the experimental front, existing studies have focused on the effects of aluminium on cultured mammary epithelial cells. We reported that concentrations of aluminium in the range of those measured in the human breast selectively transform MCF‐10A human mammary epithelial cells *in vitro* after several weeks of culture. This effect was preceded by the induction of DNA double strand breaks, whose repair is often intrinsically mutagenic, and was not reversible following aluminium withdrawal from the culture medium, thus suggesting a genetic modification of the cells. Aluminium was not detectably mutagenic in bacteria.[14](#ijc30393-bib-0014){ref-type="ref"} In another study, aluminium increased the migratory and invasive properties of MCF‐7 or MDA‐MB‐231 human breast cancer cells *in vitro*.[15](#ijc30393-bib-0015){ref-type="ref"}, [16](#ijc30393-bib-0016){ref-type="ref"}

A harmless compound is not expected to have such profound effects on the behavior of cultured cells at concentrations in the range of those measured in the organism. Experimental evidence in an animal model, however, would considerably strengthen the doubts on the safety of aluminium originating from these observations.

Due to the known difficulty of growing human cells in mouse models, we investigated the capacity of normal murine mammary gland (NMuMG) epithelial cells cultured in the presence of concentrations of aluminium in the range of those measured in the human breast to form tumors in well‐established mouse models of cancer. Like MCF‐10A cells, NMuMG cells are spontaneously immortalized and do not form malignant lesions in nude mice or in the mouse strain they were originally isolated from (NAMRU).^17,18^

Material and Methods {#ijc30393-sec-0002}
====================

Cell culture {#ijc30393-sec-0003}
------------

NMuMG cells[17](#ijc30393-bib-0017){ref-type="ref"}, [18](#ijc30393-bib-0018){ref-type="ref"} were kindly provided by Prof. R. Montesano (University of Geneva) or purchased from LGC Standards/ATCC (Molsheim Cedex, France) (cat. no. CRL‐1636) and used immediately in the experiments reported in this manuscript. The cells were cultured in Dulbecco\'s modified Eagle\'s medium (Sigma‐Aldrich, Buchs, Switzerland) (cat. no. D5796) supplemented with 10% heat‐inactivated fetal calf serum (Amimed/Bioconcept, Allschwil, Switzerland; cat. no. 2‐01F10‐I), 100 units/ml penicillin and 0.1 mg/ml streptomycin (Sigma‐Aldrich, cat. no. P0781). Aluminium chloride hexahydrate (Sigma‐Aldrich, cat. no. 06232) was dissolved in Milli‐Q H~2~O at the concentration of 1M and immediately diluted at the intermediate concentrations of 100 mM, 30 mM or 10 mM in Milli‐Q H~2~O. These stocks were stored at 4°C until used. The stocks, or Milli‐Q H~2~O as a control, were diluted 1:1,000 in fresh culture medium twice a week, at the time the medium was added to the cells.

Under standard culture conditions, NMuMG cells retained the rounded cobblestone‐like growth pattern typical of the original cell line throughout the time period required to perform the experiments reported in this study. NMuMG cells transformed by AlCl~3~ were the only transformed mouse cell line present in our laboratory.

Western blotting {#ijc30393-sec-0004}
----------------

Approximately 80% confluent (E‐cadherin) or 50% confluent (N‐cadherin) NMuMG cells cultured for 6 months in the presence of AlCl~3~ 100 μM, or of the same dilution---1/1,000---of solvent (H~2~O) alone as a control, were lysed in RIPA buffer (Sigma‐Aldrich, cat. no. R0278) supplemented with proteinase inhibitors (Sigma‐Aldrich, cat. no. P8340) and analysed by Western Blotting, using standard procedures. Antibodies (E‐cadherin: cat. no. ab76055; N‐cadherin: cat. no. ab76011; β‐actin: cat. no. ab6276; all from Abcam, Cambridge, UK) were used according to manufacturer\'s instructions. First antibody/horseradish peroxidase‐conjugate second antibody complexes were revealed with SuperSignal™ West Pico Chemiluminescent Substrate (Thermofisher cat. no. 34080) in a myECL imager (Thermofisher). Bands were quantified using myImageAnalysis version 2.01 (Thermofisher) and normalized with respect to β‐actin levels.

Soft agar assay {#ijc30393-sec-0005}
---------------

Cells were resuspended in agarose gels at the density of 2 × 10^4^ cells/ml and grown for 14 days in the presence of complete culture medium as described.[19](#ijc30393-bib-0019){ref-type="ref"} AlCl~3~ was not added to the soft agar assays.

Xenografts {#ijc30393-sec-0006}
----------

In all the xenograft experiments described, 5 × 10^6^ PBS‐washed cells were resuspended in 200 μl of growth factor reduced Matrigel (BD Biosciences, Allschwil, Switzerland; cat. no. 354230) at the final concentration of 6.5--7.0 mg/ml (depending on the specific lot used) and injected subcutaneously into one flank of 6‐week‐old female mice of the indicated strain. Except where indicated, five mice/condition were used. Mice were purchased from Charles River Laboratories (Saint‐Germain‐sur‐l\'Arbresle, France) and maintained in a specific pathogen free area. Experiments were performed according to Institutional ethics guidelines. For the NOD SCID gamma (NSG) experiment, the indicated organs were embedded in paraffin using standard procedures. Two hundreds 5 μm‐thick consecutive sections were cut. Of these, one in every ten was stained with Hematoxylin‐eosin (HE). For the Swiss nude experiment, the procedure was the same, except that 100 5 μm‐thick consecutive sections were cut, and one every ten was stained with HE. HE stained sections were screened for metastasis with the help of an expert pathologist. Immunohistochemistry for cytokeratin 7 or 19 used antibodies ab181598 or ab133496, respectively (both from Abcam, Cambridge, UK), and was performed according to manufacturer\'s instructions.

Whole‐exome sequencing of NMuMG cells {#ijc30393-sec-0007}
-------------------------------------

Whole‐exome sequencing was conducted on NMuMG cells cultured for 7 months in the presence of AlCl~3~ 100 μM or the same dilution of solvent (H~2~O) alone as a control. Libraries were prepared with the Agilent SureSelect Target Enrichment technology. Next generation sequencing was performed on an Illumina Hiseq 2500 using paired‐end 100 bp run. The variants identified were filtered through the "spin‐off" tool specific for somatic cancer mutations, MuTect (<https://www.broadinstitute.org/cancer/cga/mutect>). The indicated mutations were verified by PCR followed by Sanger sequencing, using standard procedures.

Results {#ijc30393-sec-0008}
=======

NMuMG cells were routinely cultured in the presence of AlCl~3~ 100 μM, or of the same dilution---1/1,000---of solvent (H~2~O) alone as a control. AlCl~3~ had no immediate effects on the morphology of NMuMG cells. After 14--16 weeks of continuous exposure to AlCl~3~---corresponding approximately to 42 population doublings---however, NMuMG cells acquired a fibroblastoid morphology and a scattered growth pattern reminiscent of epithelial‐mesenchymal transition (EMT), a hallmark of malignant transformation[20](#ijc30393-bib-0020){ref-type="ref"} (Fig. [1](#ijc30393-fig-0001){ref-type="fig"} *a*, bottom). Control NMuMG cells, in contrast, exhibited the rounded cobblestone‐like growth pattern typical of these cells (Fig. [1](#ijc30393-fig-0001){ref-type="fig"} *a*, top). Decrease of E‐cadherin and increase of N‐cadherin expression are two well‐established markers of EMT.[20](#ijc30393-bib-0020){ref-type="ref"} Western Blotting revealed, on average, a 63% decrease in E‐cadherin and a 3.7‐fold increase in N‐cadherin expression in NMuMG cells incubated in the presence of AlCl~3~, compared to controls (Figs. [1](#ijc30393-fig-0001){ref-type="fig"} *b* and [1](#ijc30393-fig-0001){ref-type="fig"} *c*). In the soft agar assay, a well‐characterized method to assess cellular transformation *in vitro*, AlCl~3~‐treated NMuMG cells formed larger colonies compared to controls (Figs. [2](#ijc30393-fig-0002){ref-type="fig"} *a* and [2](#ijc30393-fig-0002){ref-type="fig"} *b*). NMuMG cells from another source (ATCC) gave similar results in the soft agar assay (Fig. [2](#ijc30393-fig-0002){ref-type="fig"} *c*). These findings confirm and extend the results we obtained with MCF‐10A human mammary epithelial cells.[14](#ijc30393-bib-0014){ref-type="ref"}

![(*a*) Phase contrast view of NMuMG cells incubated for 4 months in the presence of AlCl~3~ 100 μM (bottom) or the same volume (1/1,000) of solvent (H~2~O) alone as a control (top). AlCl~3~ or H~2~O were renewed twice a week with fresh culture medium. Bar = 100 μm. (*b*) Approximately 80% confluent NMuMG cells cultured for 6 months in the presence of AlCl~3~ 100 μM, or of the same dilution---1/1,000---of solvent (H~2~O) alone as a control were analysed for the expression of E‐cadherin, or β‐actin as a loading control, by Western Blotting. One representative gel (out of 6) is shown. The bands presented were from the same gel. The graph shows the mean values for E‐cadherin expression, obtained in densitometric analysis, ± SEM, from six experiments, normalized with respect to β‐actin levels. Control (H~2~O) was set to 1. *p* H~2~O *versus* AlCl~3~ 100 μM = 0.00038 (two‐tailed *t*‐test). (*c*) Same experiment as in (*b*), except that (*i*) cells were approximately 50% confluent; (*ii*) analysis was for N‐cadherin; (*iii*) the number of experiments was 4; (*iv*) *p* H~2~O *versus* AlCl~3~ 100 μM = 0.0023 (two‐tailed *t*‐test). \[Color figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com).\]](IJC-139-2781-g001){#ijc30393-fig-0001}

![AlCl~3~ transforms NMuMG cells *in vitro*. (*a*) NMuMG cells cultured for 4 months in the presence of AlCl~3~ 100 μM or the equivalent volume of H~2~O as control were resuspended in agarose gels at the density of 2 × 10^4^ cells/ml and grown for 14 days in the presence of complete culture medium. AlCl~3~ was not added to the soft agar assay. Bar = 100 μm. (*b*) The growth in agarose gels was quantified by measuring the diameter of the structures (single cells or multicellular colonies) formed after 14 days. At least 50 randomly selected structures (single cells or multicellular colonies) from two independent experiments/condition were measured. *p* AlCl~3~ *versus* H~2~O = 6.71E‐04 (two‐tailed *t*‐test). (*c*) The graph shows the growth in agarose of NMuMG cells from a different source (ATCC), cultured for 7 months in the presence of AlCl~3~ 10 μM, AlCl~3~ 100 μM or the equivalent volume of H~2~O as control, as indicated. The soft agar assay was as described in *a*, *b*. *p* AlCl~3~ 10 μM *versus* H~2~O = 0.02; *p* AlCl~3~ 100 μM *versus* H~2~O = 2.79E‐05 (two‐tailed *t*‐test). \[Color figure can be viewed at [wileyonlinelibrary.com](http://wileyonlinelibrary.com).\]](IJC-139-2781-g002){#ijc30393-fig-0002}

As a next step, we wished to determine if NMuMG cells cultured in the presence of AlCl~3~ form tumors in mice. The NAMRU mouse strain being no longer available, we used three mouse models having different degrees of immunodeficiency. For these experiments, we selected NMuMG cells grown in the presence of 100 μM AlCl~3~, as they exhibit the most marked signs of cellular transformation *in vitro* (Figs. [1](#ijc30393-fig-0001){ref-type="fig"} *a* and 2). NMuMG cells grown in parallel in the presence of the same dilution of H~2~O were used as controls.

For the first experiment, we used the NOD.Cg‐*Prkdc^scid^Il2rg^tm1Wjl^*/SzJ strain, commonly referred to as NOD SCID gamma (NSG). NSG mice lack mature T cells, B cells, and functional natural killer (NK) cells, and are deficient in cytokine signaling, leading to successful engraftment of normal and transformed cell types. In the NSG strain, both NMuMG cells cultured in the presence of AlCl~3~ 100 μM and their corresponding controls formed palpable tumors at the site of injection. However, tumors formed by AlCl~3~‐treated cells were significantly larger (Fig. [3](#ijc30393-fig-0003){ref-type="fig"} *a*).

![AlCl~3~ promotes tumorigenesis and lung metastasis in NMuMG cells injected subcutaneously into NSG mice. Five million NMuMG cells cultured for 6 months in the presence of AlCl~3~ 100 μM or the equivalent volume of H~2~O as control were resuspended in 200 μl of Matrigel and injected subcutaneously into the flank of 6‐week‐old NSG female mice. Five mice/condition were used. The mice were sacrificed 6 weeks after injection. The graphs show (*a*) the volume of each tumor (calculated according to the formula 4/3π × *a* × *b* × *c*, with *a*, *b*, *c* corresponding each to ½ of the three axis of the tumor, approximated to an ellipsoid, respectively) or (*b*) the weight of each mouse at the time of sacrifice. Tumor incidence was 100% (all the mice formed tumors). Statistics were as follows. For tumor volume, H~2~O *versus* AlCl~3~ 100 μM: *p* = 0.01, two‐tailed *t‐*test. For mouse weight, H~2~O *versus* AlCl~3~ 100 μM: *p* = 0.01, two‐tailed *t‐*test. (*c*) Macroscopic apical view (upper panel) or ventral view (lower panel) of the lungs of a NSG female mouse injected with AlCl~3~‐treated NMuMG cells or H~2~O‐treated NMuMG cells, as indicated, at the time of sacrifice.](IJC-139-2781-g003){#ijc30393-fig-0003}

One week before sacrifice---that is, 5 weeks after injection---mice injected with AlCl~3~‐treated cells had lost weight and looked sick. They became progressively unable to move around and to eat. In contrast, mice injected with control cells retained normal weight and exhibited the usual behavior of healthy animals. At the time of sacrifice, mice injected with control cells weighted 24.9 ± 0.4 (mean ± SEM) g, whereas mice injected with AlCl~3~‐treated cells weighted 20.6 ± 1.3 (mean ± SEM) g (Fig. [3](#ijc30393-fig-0003){ref-type="fig"} *b*).

At the time of dissection, the lightest mouse injected with AlCl~3~‐treated cells had massive, macroscopically visible metastasis in the lungs (Fig. [3](#ijc30393-fig-0003){ref-type="fig"} *c*, right; Fig. [4](#ijc30393-fig-0004){ref-type="fig"} *b*). This mouse also had liver and brain metastasis (Supporting Information Fig. S1 and data not shown). Of the four remaining mice injected with AlCl~3~ --treated NMuMG cells, all had massive metastasis in the lungs. These frequently presented with a central area of necrosis (Fig. [4](#ijc30393-fig-0004){ref-type="fig"} *b*). One of the remaining four mice injected with AlCl~3~---treated NMuMG cells also had metastasis in the cerebellum (Fig. [5](#ijc30393-fig-0005){ref-type="fig"}). Like the tumors grown at the site of injection, metastases were labeled by the epithelial markers cytokeratin 7 and 19 (Supporting Information Fig. S1, 5 and data not shown). In mice injected with control cells, only lung metastases were observed (Fig. [4](#ijc30393-fig-0004){ref-type="fig"} *a*). These were smaller and less numerous than in mice injected with AlCl~3~‐treated NMuMG cells. By counting metastases in the lungs of either groups on randomly selected HE stained sections, we found 2.4 ± 0.9 (mean ± SEM) metastasis/45 mm^2^ in the group injected with control NMuMG cells, and 11.8 ± 2.0 (mean ± SEM) metastasis/45 mm^2^ in the group injected with AlCl~3~‐treated NMuMG cells (*p* = 0.003, two‐tailed *t* test; *n* = 5 mice/group). HE staining found no metastases in the heart, spleen or kidneys of the two experimental groups.

![HE stained sections of the lungs of a NSG female mouse injected with (*b*) NMuMG cells cultured in the presence of AlCl~3~ 100 μM for 6 months or (*a*) NMuMG cells incubated for 6 months in the presence of a 1/1,000 dilution of H~2~O. The mice were from the same experiment described in Figure 3. In (*b*), the inset shows necrotic cells. Bar in *a* and *b* = 50 μm.](IJC-139-2781-g004){#ijc30393-fig-0004}

![AlCl~3~ promotes tumorigenesis and brain metastasis in NMuMG cells injected subcutaneously into NSG mice. (*a*) HE stained sections of the cerebellum of a NSG female mouse injected with NMuMG cells cultured in the presence of AlCl~3~ 100 μM for 6 months. The mouse was from the same experiment described in Figure 3. (*b*) Cytokeratin 7 or (*c*) cytokeratin 19 immunohistochemistry on adjacent sections. Bar in *a*, *b*, *c* = 50 μm.](IJC-139-2781-g005){#ijc30393-fig-0005}

As a next step, we injected AlCl~3~‐treated NMuMG cells, or their untreated counterparts, in the NOD.CB17‐*Prkdc^scid^*/J mouse strain (commonly referred to as NOD SCID). This strain is characterized by an absence of functional T cells and B cells, lymphopenia, hypogammaglobulinemia and a normal hematopoietic microenvironment. In contrast to NSG mice, NOD SCID mice have NK cells.

In the NOD SCID strain, AlCl~3~‐treated NMuMG cells formed palpable tumors with a kinetics similar to that observed in the NSG strain. In contrast to NSG mice, however, control NMuMG cells did not grow beyond the volume of injection during the same period of time (Fig. [6](#ijc30393-fig-0006){ref-type="fig"} *a*). At the time of sacrifice, the general health status of the animals was similar in the two experimental groups. Also, the weight of the mice was not significantly different between the two groups (mice injected with AlCl~3~‐treated NMuMG cells weighted 23.4 ± 1.0 (mean ± SEM) g, whereas mice injected with H~2~O‐treated NMuMG cells weighted 22.7 ± 0.5 (mean ± SEM) g, *p* = 0.56, two‐tailed *t* test, *n* = 5 mice/group). At dissection, metastases were macroscopically visible in the lungs of mice injected with AlCl~3~‐treated cells, but not in the lungs of mice injected with control NMuMG cells (data not shown).

![AlCl~3~ promotes tumorigenesis and metastasis in NMuMG cells injected subcutaneously into NOD SCID and nude mice. (*a*) Five million NMuMG cells cultured for 8 months in the presence of AlCl~3~ 100 μM or the equivalent volume of H~2~O as control were resuspended in 200 μl of Matrigel and injected subcutaneously into the flank of 6‐week‐old NOD SCID female mice. Five mice/condition were used. Cell growth at the site of injection was measured with a caliper. The graph shows the volume ± SEM of such growth (calculated according to the formula *V* (mm^3^) = *d* ^2^ (mm^2^) × *D* (mm)/2, where *d* and *D* are the smallest and largest tumor diameters, respectively) at the indicated number of days after injection. Tumor incidence was 100% (all the mice injected with AlCl~3~‐treated cells formed tumors). *p* values (two‐tailed *t*‐test) comparing the two experimental groups were as follows: 7 days: *p* = 0.37; 13 days: *p* = 0.02; 24 days: *p* = 0.001; 32, 39 and 45 days: *p* \< 0.001. (*b*) Five million NMuMG cells cultured for 8 months in the presence of AlCl~3~ 100 μM or the equivalent volume of H~2~O as control were resuspended in 200 μl of Matrigel and injected subcutaneously into the flank of 6‐week‐old Swiss nude female mice. Five mice were used for AlCl~3~‐treated cells, and four mice for control cells (the fifth mouse planned to be injected with control cells died during anesthesia at the time of injection). Cell growth at the site of injection was measured with a caliper. The graph shows the volume ± SEM of such growth (calculated according to the formula *V* (mm^3^) = *d* ^2^ (mm^2^) × *D* (mm)/2, where *d* and *D* are the smallest and largest tumor diameters, respectively) at the indicated number of days after injection. Tumor incidence was 100% (all the mice injected with AlCl~3~‐treated cells formed tumors). *p* values comparing the two experimental groups were as follows: 7 days: *p* = 0.11; 14 days: *p* = 0.0049; 21 days: *p* = 0.0017; 28 and 35 days: *p* \< 0.003 (two‐tailed *t*‐test). (*c*) HE stained section (left) or cytokeratin 19 immunohistochemistry on an adjacent section (right) showing a lung metastasis in a Swiss nude mouse injected with AlCl~3~‐treated NMuMG cells. Bar = 50 μm.](IJC-139-2781-g006){#ijc30393-fig-0006}

As a next step, AlCl~3~‐treated NMuMG cells, or their corresponding controls, were injected subcutaneously into Swiss nude mice (Crl:NU‐*Foxn1^nu^* strain). Of the mouse strains used in our experiments, this is the less immunodeficient one. Swiss nude mice are athymic and hairless as a result of the recessive *nu* mutation. T cell precursors exist but development is blocked in the absence of a thymus. In contrast, they have normal B cells and normal numbers and functions of macrophages, NK cells and antigen presenting cells.

In Swiss nude mice, AlCl~3~‐treated NMuMG cells formed palpable tumors with a kinetics similar to that observed in NOD SCID mice (Figs. [6](#ijc30393-fig-0006){ref-type="fig"}a, 6b). In contrast, control NMuMG cells did not grow beyond the volume of injection during the same period of time (Fig. [6](#ijc30393-fig-0006){ref-type="fig"} *b*). At the time of sacrifice, mouse weight was similar in the two groups (mice injected with control cells weighted 24.17 ± 1.28 (mean ± SEM) g whereas the mice injected with AlCl~3~‐treated cells weighted 26.34 ± 0.79 (mean ± SEM) g (*p* = 0.20, two‐tailed *t* test; *n* = 4 mice for control NMuMG cells; *n* = 5 mice for AlCl~3~‐treated NMuMG cells)).

The lungs of 3/5 Swiss nude mice injected with AlCl~3~‐treated NMuMG cells had metastases as assessed by HE staining and cytokeratin 19 staining (Fig. [6](#ijc30393-fig-0006){ref-type="fig"} *c*). In contrast, 4/4 mice injected with control NMuMG cells did not have lung metastasis. No metastases were observed in HE stained sections of the brain, kidneys, spleen, heart or liver of either groups.

After the initial culture in the presence of AlCl~3~, AlCl~3~ was not added to the soft agar or tumor cell xenograft assays, where NMuMG cells exhibit a proliferative advantage. Similarly, growth in soft agar of MCF‐10A cells cultured in the presence of AlCl~3~ was not reduced after AlCl~3~ withdrawal for 5 weeks.[14](#ijc30393-bib-0014){ref-type="ref"} This suggests that the growth advantage observed in mammary epithelial cells cultured in the presence of AlCl~3~ could be due to mutations induced by AlCl~3~. We previously reported that AlCl~3~ induces DNA double strand breaks, a common source of mutation, in cultured mammary epithelial cells.[14](#ijc30393-bib-0014){ref-type="ref"} To explore the possibility that AlCl~3~ had induced mutations in NMuMG cells, whole‐exome sequencing was conducted on AlCl~3~‐treated NMuMG cells or NMuMG cells grown in parallel in the presence of the same dilution of solvent (H~2~O) alone as a control.

We found 48 mutations affecting 43 genes in AlCl~3~‐treated *versus* control NMuMG cells (Supporting Information Table S1). Direct sequencing on 18 such mutations was successful in 14 cases and confirmed the mutation in 13 cases (92.8%; Supporting Information Table S1) consistent with the very low false positive rate of MuTect (<https://www.broadinstitute.org/cancer/cga/mutect>). The mutations affect genes regulating cellular proliferation, migration, metastasis and apoptosis, including Max‐binding protein *Mnt* [21](#ijc30393-bib-0021){ref-type="ref"}, [22](#ijc30393-bib-0022){ref-type="ref"} and T‐lymphoma invasion and metastasis‐inducing protein 2 (*Tiam2*)[23](#ijc30393-bib-0023){ref-type="ref"} (Supporting Information Table S1). Although AlCl~3~‐treated NMuMG cells clearly exhibit a proliferative advantage in the soft agar and xenograft assays, AlCl~3~ does not increase proliferation in the conventional, two‐dimensional culture system used to produce these cells (Supporting Information Fig. S2), thus ruling out the possibility that the mutations found in AlCl~3~‐treated NMuMG cells are simply a consequence of increased proliferation.

Discussion {#ijc30393-sec-0009}
==========

Although it is generally acknowledged that aluminium is neurotoxic, its widespread distribution in industrial products of daily use seems to reflect a general belief that, at least when used at certain concentrations and in certain formulations, aluminium is innocuous to human health. By several variations of the Ames test, one of the most common biological assays used in the industry to assess the mutagenic potential of chemical compounds, aluminium is not detectably mutagenic in bacteria.[14](#ijc30393-bib-0014){ref-type="ref"} Whereas this result might seem reassuring, accumulating experimental evidence on the effects of aluminium in mammalian systems is opening an unsuspected scenario.

The results obtained in cultured mammary epithelial cells are perhaps the most intriguing ones. In the large majority of commercial antiperspirants, aluminium is present as AlCl~3~ or, more frequently, as aluminium chlorohydrate (Al~2~Cl(OH)~5~) at concentrations up to several molar units (see Introduction). In aqueous solutions at pH 7.0, both salts yield aluminium hydroxide and they are absorbed through the human and mouse skin.^6--9^ It is, therefore, conceivable that the daily application of antiperspirants to the skin of the underarm represents a major source of exposure of the human mammary epithelium to aluminium. Although aluminium concentrations in the body are generally low, levels measured in the breast area are significantly higher. More specifically, Al concentrations were in the range of 150--520 μg/l (mean 268.4 ± 28.1 μg/l), corresponding to 5.6--19.3 μM, in nipple aspirate fluids[11](#ijc30393-bib-0011){ref-type="ref"}; in the range of 80--330 μg/l (median 150 μg/l) corresponding to 3.0--12.2 μM, in type I breast cyst fluids[10](#ijc30393-bib-0010){ref-type="ref"}; or in the range of 4--437 nmol/g dry weight, corresponding to 0.8--87 nmol/g wet weight in human breast tissue.[12](#ijc30393-bib-0012){ref-type="ref"} Assuming that 1 g of tissue has a volume of 1 ml, then overall concentrations of aluminium in the human breast are in the range of 0.8--87 μM. It appears relevant that the reported transforming and invasion promoting effects of aluminium on cultured mammary epithelial cells^14--16^ (this study) occur at aluminium concentrations within o very close to the range of those measured in the human breast.

Like MCF‐10A cells,[14](#ijc30393-bib-0014){ref-type="ref"} NMuMG cells cultured in the presence of AlCl~3~ 10--100 μM undergo cellular transformation *in vitro,* as assessed by the soft agar assay. Regarding the xenografts experiments, although in the NSG model both AlCl~3~‐treated and control NMuMG cells form tumors and metastasize, tumors formed by AlCl~3~‐treated NMuMG cells were larger than those formed by control cells. Metastases to the lungs were fivefold more numerous in mice injected with AlCl~3~ treated cells, compared to the lungs of mice injected with control cells. In addition, in NSG mice, AlCl~3~‐treated cells metastasized to the brain and the liver, whereas control cells did not. Therefore, in the three mouse models used, including nude mice, the most used mouse strain in experimental oncology and drug testing, AlCl~3~‐treated NMuMG cells are markedly more aggressive than their controls. In addition, our results demonstrate that continuous exposure of mammary epithelial cells to aluminium enables them to evade the immunological barrier represented by NK cells and the other immune tumor suppressive cells present in NOD SCID or nude mice, a key step in malignant tumor progression. These effects are likely to be explained at least in part by the mutagenic activity of AlCl~3~, because selection for mutations that provide a proliferative advantage is a well‐recognized mechanism of malignancy. EMT induced in NMuMG cells by AlCl~3~ is also likely to contribute to their invasive phenotype.

Aluminium is not the only metal with carcinogenic properties. Known examples include certain forms of arsenic, beryllium, chromium, nickel and cadmium. For some of these metals---in particular arsenic and hexavalent chromium---the carcinogenic effect seems to rely on their mutagenic potential, although other mechanisms cannot be excluded.[24](#ijc30393-bib-0024){ref-type="ref"} In the case of aluminium, its transforming effect is preceded by the dose‐dependent appearance of DNA double strand breaks at the same concentrations that transform cells on long‐term culture.[14](#ijc30393-bib-0014){ref-type="ref"} As the repair of DNA double strand breaks is error‐prone, and the transformed phenotype of MCF‐10A cells cultured in the presence of AlCl~3~ is not reverted by AlCl~3~ withdrawal,[14](#ijc30393-bib-0014){ref-type="ref"} it appears conceivable that the transforming effect of aluminium relies at least in part on a mutagenic effect. Consistent with this interpretation, by full exome sequencing we found several mutations in AlCl~3~‐treated NMuMG cells compared to controls. These mutations occurred in genes regulating cellular proliferation, migration, metastasis and apoptosis, Max‐binding protein *Mnt* [21](#ijc30393-bib-0021){ref-type="ref"}, [22](#ijc30393-bib-0022){ref-type="ref"} and T‐lymphoma invasion and metastasis‐inducing protein 2 (*Tiam2*)[23](#ijc30393-bib-0023){ref-type="ref"} being the most interesting mutated cancer genes in the list presenting with a high PolyPhen‐2 score (Supporting Information Table S1). The actual contribution of these mutations to the transforming effect of aluminium, if any, remains to be demonstrated.

Conclusive evidence on the carcinogenic potential of aluminium requires epidemiological studies in humans and *in vivo* experiments were aluminium is directly applied to the skin of mice. In addition, it would be interesting to isolate and grow primary cultures of mouse mammary epithelial cells in the presence of AlCl~3~, prior to tumorigenicity assays in syngenic mice. Whereas these evidences are awaited, the *in vivo* observations reported in this study consolidate our previous *in vitro* findings[14](#ijc30393-bib-0014){ref-type="ref"} and provide additional experimental evidence that aluminium salts could be environmental breast carcinogens.
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